French multinational pharma Sanofi (SNYNF) can produce as many as 600 million doses of its coronavirus vaccine next year if everything goes to …
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi (NYSE:SNY) announced that the FDA approved DUPIXENT® (dupilumab) Injection, the first and only biologic medicine approved for …
Google parent Alphabet Inc (NASDAQ:GOOGL) was founded in 2015 to allow for more transparency regarding the company’s subsidiaries that are unrelated to its core …
Europe has a better investing environment as the United States. The ECB currently runs a 60 billion monthly quantitative easing program for the …
In a research note released Monday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Regeneron Pharmaceuticals, Inc. (REGN) and a price target of $382.
